![Srinivas N. Pentyala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Srinivas N. Pentyala
Directeur/Bestuurslid bij Translational Research Group, Inc.
Profiel
Srinivas N.
Pentyala is a Director of Affinimark Technologies, Inc. He is a Faculty Member of Anesthesiology, Urology, Health sciences, Physiology, and Biophysics at the Medical School of the State University of New York.
Dr. Pentyala is a Director for Translational Research.
He is a Course Director for the New York State Center for Biotechnology.
Dr. Pentyala worked as a Professor and Faculty Member at Stony Brook University.
He holds a PhD.
Actieve functies van Srinivas N. Pentyala
Bedrijven | Functie | Begin |
---|---|---|
The State University of New York | Corporate Officer/Principal | - |
Translational Research Group, Inc. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Srinivas N. Pentyala
Bedrijven | Functie | Einde |
---|---|---|
Stony Brook University | Corporate Officer/Principal | - |
Affinimark Technologies, Inc.
![]() Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Affinimark Technologies, Inc.
![]() Affinimark Technologies, Inc. Medical SpecialtiesHealth Technology Affinimark Technologies, Inc. develops proprietary medical diagnostic products. Its products address lucrative market opportunities and serious unmet medical/surgical needs and its lead product, cerebrostripTM, is a strip-based diagnostic test, derived from affinimark's own cutting edge research that will quickly and cost-effectively provide a definitive determination whether the patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. The company was founded by Harry H. Penner, Jr. and Levesque Christopher in 2007 and is headquartered in New Haven, CT. | Health Technology |
Translational Research Group, Inc. |